Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
about
Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancer.Posterior Reversible Encephalopathy Syndrome in Patients With CancerPosterior reversible leukoencephalopathy syndrome associated with pazopanib.Ocular side effects of biological agents in oncology: what should the clinician be aware of?Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature.Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?"Neurological complications of new chemotherapy agents".Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma.Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.
P2860
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
P2860
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@ast
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@en
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@nl
type
label
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@ast
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@en
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@nl
prefLabel
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@ast
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@en
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@nl
P2093
P2860
P356
P1433
P1476
Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
@en
P2093
Eleni Chamalidou
Evagelos Christakidis
Kiriakos Amarantidis
Leonidas Chelis
Nikolaos Xenidis
Panagiotis Prassopoulos
Prodromos Michailidis
Prokopios Dimopoulos
Stylianos Kakolyris
Vasilios Souftas
P2860
P2888
P356
10.1186/1471-2407-12-489
P407
P577
2012-10-22T00:00:00Z
P5875
P6179
1000490579